Celldex Therapeutics Inc
CLDX22.270USD
+0.080+0.36%
交易中 （美东）报价延迟15分钟
1.48B总市值
亏损市盈率 TTM
关于 Celldex Therapeutics Inc 公司
Celldex Therapeutics, Inc. 是一家生物制药公司。该公司专注于探索肥大细胞生物学科学和为患者开发变革性疗法。其候选药物包括单克隆抗体和双特异性抗体，旨在治疗现有治疗方法不足的肥大细胞介导疾病。其 Barzolvolimab 是一种单克隆抗体，可特异性结合 KIT 受体并有效抑制其活性，该药物针对多种肥大细胞驱动疾病进行了研究，包括慢性荨麻疹、结节性痒疹和嗜酸性食管炎。该公司的双特异性抗体平台支持管道扩展，并增加针对炎症疾病和肿瘤学的候选药物。双特异性平台包括 CDX-585。CDX-585 结合了其高活性 PD-1 阻断剂和抗 ILT4 阻断剂，分别可克服 T 细胞和髓系细胞中的免疫抑制信号。
公司简介
公司代码CLDX
公司名称Celldex Therapeutics Inc
上市日期May 15, 1986
CEOMr. Anthony S. Marucci
员工数量186
证券类型Ordinary Share
年结日May 15
公司地址53 Frontage Road
城市HAMPTON
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编08827
电话19084547120
网址https://celldex.com/
公司代码CLDX
上市日期May 15, 1986
CEOMr. Anthony S. Marucci
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.64K
+1.48%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
34.14K
+38.79%
Dr. Diane C. Young, M.D.
Dr. Diane C. Young, M.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
17.11K
-63.67%
Dr. Margo Heath-Chiozzi, M.D.
Dr. Margo Heath-Chiozzi, M.D.
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
13.74K
+2.70%
Ms. Elizabeth Crowley
Ms. Elizabeth Crowley
Senior Vice President, Chief Product Development Officer
Senior Vice President, Chief Product Development Officer
9.07K
--
Dr. Tibor Keler, Ph.D.
Dr. Tibor Keler, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
7.36K
--
Mr. Herbert J. (Herb) Conrad
Mr. Herbert J. (Herb) Conrad
Independent Director
Independent Director
2.56K
--
Mr. James J. (Jim) Marino
Mr. James J. (Jim) Marino
Independent Director
Independent Director
2.20K
--
Mr. Keith L. Brownlie, CPA
Mr. Keith L. Brownlie, CPA
Independent Director
Independent Director
666.00
--
Ms. Denice M. Torres, J.D.
Ms. Denice M. Torres, J.D.
Director
Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.64K
+1.48%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
34.14K
+38.79%
Dr. Diane C. Young, M.D.
Dr. Diane C. Young, M.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
17.11K
-63.67%
Dr. Margo Heath-Chiozzi, M.D.
Dr. Margo Heath-Chiozzi, M.D.
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
13.74K
+2.70%
Ms. Elizabeth Crowley
Ms. Elizabeth Crowley
Senior Vice President, Chief Product Development Officer
Senior Vice President, Chief Product Development Officer
9.07K
--
Dr. Tibor Keler, Ph.D.
Dr. Tibor Keler, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
7.36K
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
Wellington Management Company, LLP
12.58%
Kynam Capital Management LP
9.79%
BlackRock Institutional Trust Company, N.A.
6.97%
Fidelity Management & Research Company LLC
5.85%
The Vanguard Group, Inc.
5.85%
Other
58.95%
持股股东
持股股东
占比
Wellington Management Company, LLP
12.58%
Kynam Capital Management LP
9.79%
BlackRock Institutional Trust Company, N.A.
6.97%
Fidelity Management & Research Company LLC
5.85%
The Vanguard Group, Inc.
5.85%
Other
58.95%
股东类型
持股股东
占比
Investment Advisor
45.68%
Hedge Fund
31.15%
Investment Advisor/Hedge Fund
29.65%
Research Firm
3.45%
Venture Capital
2.56%
Bank and Trust
0.33%
Pension Fund
0.31%
Individual Investor
0.27%
Insurance Company
0.04%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
419
75.39M
113.55%
-14.43M
2025Q1
437
75.31M
113.46%
-13.68M
2024Q4
437
75.05M
113.05%
-8.14M
2024Q3
429
73.28M
110.59%
-7.16M
2024Q2
432
71.48M
107.86%
-10.62M
2024Q1
419
71.32M
108.50%
+952.72K
2023Q4
406
62.72M
112.33%
-412.93K
2023Q3
403
52.10M
110.18%
-8.63M
2023Q2
410
51.84M
109.57%
-7.47M
2023Q1
419
51.38M
108.89%
-6.42M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Wellington Management Company, LLP
8.35M
12.58%
-621.68K
-6.93%
Mar 31, 2025
Kynam Capital Management LP
6.50M
9.79%
+1.44M
+28.35%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.62M
6.97%
-29.87K
-0.64%
Mar 31, 2025
Fidelity Management & Research Company LLC
3.89M
5.85%
+441.18K
+12.80%
Mar 31, 2025
The Vanguard Group, Inc.
3.89M
5.85%
+16.44K
+0.42%
Mar 31, 2025
Eventide Asset Management, LLC
3.75M
5.66%
+1.53K
+0.04%
Mar 31, 2025
T. Rowe Price Associates, Inc.
3.35M
5.05%
-144.43K
-4.13%
Mar 31, 2025
Commodore Capital LP
3.35M
5.05%
+150.00K
+4.69%
Apr 03, 2025
Bellevue Asset Management AG
3.07M
4.63%
--
--
Mar 31, 2025
State Street Global Advisors (US)
2.81M
4.23%
-428.60K
-13.25%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
ALPS Medical Breakthroughs ETF
0.91%
Virtus LifeSci Biotech Clinical Trials ETF
0.9%
SPDR S&P Biotech ETF
0.37%
Direxion Daily S&P Biotech Bull 3X Shares
0.21%
Nuveen ESG Small-Cap ETF
0.11%
Fidelity Fundamental Small-Mid Cap ETF
0.11%
T Rowe Price Small-Mid Cap ETF
0.1%
iShares Russell 2000 Value ETF
0.1%
Avantis US Small Cap Equity ETF
0.09%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.07%
查看更多
ALPS Medical Breakthroughs ETF
占比0.91%
Virtus LifeSci Biotech Clinical Trials ETF
占比0.9%
SPDR S&P Biotech ETF
占比0.37%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.21%
Nuveen ESG Small-Cap ETF
占比0.11%
Fidelity Fundamental Small-Mid Cap ETF
占比0.11%
T Rowe Price Small-Mid Cap ETF
占比0.1%
iShares Russell 2000 Value ETF
占比0.1%
Avantis US Small Cap Equity ETF
占比0.09%
JPMorgan BetaBuilders US Small Cap Equity ETF
占比0.07%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
